Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ZYDUS LIFESCIENCES vs LUPIN - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ZYDUS LIFESCIENCES LUPIN ZYDUS LIFESCIENCES/
LUPIN
 
P/E (TTM) x 34.2 40.7 84.1% View Chart
P/BV x 5.8 6.0 96.5% View Chart
Dividend Yield % 0.6 0.2 241.4%  

Financials

 ZYDUS LIFESCIENCES   LUPIN
EQUITY SHARE DATA
    ZYDUS LIFESCIENCES
Mar-23
LUPIN
Mar-23
ZYDUS LIFESCIENCES/
LUPIN
5-Yr Chart
Click to enlarge
High Rs495799 62.0%   
Low Rs319583 54.8%   
Sales per share (Unadj.) Rs170.3365.8 46.6%  
Earnings per share (Unadj.) Rs19.89.8 201.0%  
Cash flow per share (Unadj.) Rs26.929.2 92.2%  
Dividends per share (Unadj.) Rs6.004.00 150.0%  
Avg Dividend yield %1.50.6 254.5%  
Book value per share (Unadj.) Rs173.0270.7 63.9%  
Shares outstanding (eoy) m1,012.20454.98 222.5%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.41.9 126.6%   
Avg P/E ratio x20.670.2 29.3%  
P/CF ratio (eoy) x15.123.7 63.9%  
Price / Book Value ratio x2.42.6 92.2%  
Dividend payout %30.340.7 74.6%   
Avg Mkt Cap Rs m412,144314,381 131.1%   
No. of employees `000NANA-   
Total wages/salary Rs m24,56430,872 79.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m172,374166,417 103.6%  
Other income Rs m4,7461,509 314.5%   
Total revenues Rs m177,120167,926 105.5%   
Gross profit Rs m29,67717,206 172.5%  
Depreciation Rs m7,2278,807 82.1%   
Interest Rs m1,2992,743 47.4%   
Profit before tax Rs m25,8977,165 361.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,8782,688 218.7%   
Profit after tax Rs m20,0194,477 447.2%  
Gross profit margin %17.210.3 166.5%  
Effective tax rate %22.737.5 60.5%   
Net profit margin %11.62.7 431.7%  
BALANCE SHEET DATA
Current assets Rs m100,082124,513 80.4%   
Current liabilities Rs m55,26792,654 59.6%   
Net working cap to sales %26.019.1 135.8%  
Current ratio x1.81.3 134.8%  
Inventory Days Days5026 191.8%  
Debtors Days Days9498 95.2%  
Net fixed assets Rs m144,776103,490 139.9%   
Share capital Rs m1,012910 111.2%   
"Free" reserves Rs m174,146122,246 142.5%   
Net worth Rs m175,158123,156 142.2%   
Long term debt Rs m0275 0.0%   
Total assets Rs m244,940228,003 107.4%  
Interest coverage x20.93.6 579.6%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.70.7 96.4%   
Return on assets %8.73.2 274.9%  
Return on equity %11.43.6 314.4%  
Return on capital %15.58.0 193.4%  
Exports to sales %39.20-   
Imports to sales %11.90-   
Exports (fob) Rs m67,577NA-   
Imports (cif) Rs m20,544NA-   
Fx inflow Rs m67,57748,057 140.6%   
Fx outflow Rs m20,54421,752 94.4%   
Net fx Rs m47,03326,306 178.8%   
CASH FLOW
From Operations Rs m26,88818,972 141.7%  
From Investments Rs m11,712-12,868 -91.0%  
From Financial Activity Rs m-44,004-3,373 1,304.8%  
Net Cashflow Rs m-5,3382,732 -195.4%  

Share Holding

Indian Promoters % 75.0 46.8 160.4%  
Foreign collaborators % 0.0 0.3 -  
Indian inst/Mut Fund % 18.0 45.8 39.3%  
FIIs % 5.0 16.1 31.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 53.0 47.2%  
Shareholders   306,495 281,542 108.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ZYDUS LIFESCIENCES With:   SUN PHARMA    CIPLA    DIVIS LABORATORIES    DR. REDDYS LAB    MANKIND PHARMA    


More on Cadila Healthcare vs Lupin

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Cadila Healthcare vs Lupin Share Price Performance

Period Cadila Healthcare Lupin S&P BSE HEALTHCARE
1-Day 0.57% 1.23% 1.18%
1-Month 7.77% 0.15% -0.75%
1-Year 107.52% 151.14% 61.82%
3-Year CAGR 32.30% 17.13% 18.16%
5-Year CAGR 24.52% 17.42% 19.79%

* Compound Annual Growth Rate

Here are more details on the Cadila Healthcare share price and the Lupin share price.

Moving on to shareholding structures...

The promoters of Cadila Healthcare hold a 75.0% stake in the company. In case of Lupin the stake stands at 47.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Cadila Healthcare and the shareholding pattern of Lupin.

Finally, a word on dividends...

In the most recent financial year, Cadila Healthcare paid a dividend of Rs 6.0 per share. This amounted to a Dividend Payout ratio of 30.3%.

Lupin paid Rs 4.0, and its dividend payout ratio stood at 40.7%.

You may visit here to review the dividend history of Cadila Healthcare, and the dividend history of Lupin.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.